We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+59.82%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
-$72.8M
Cap. Flow %
-4.7%
Top 10 Hldgs %
49.99%
Holding
236
New
61
Increased
26
Reduced
57
Closed
43

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$20.1M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$17.8M
3
RDUS
Radius Health, Inc.
RDUS
+$15.9M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$14.4M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$13.6M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$45.8M
2
TSRO
TESARO, Inc.
TSRO
+$43.1M
3
NVRO
NEVRO CORP.
NVRO
+$31.9M
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$25.3M
5
STJ
St Jude Medical
STJ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.62%
2 Miscellaneous 2.58%
3 Consumer Staples 0.5%
4 Technology 0.1%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
51
PUT
DELISTED
Dynavax Technologies
DVAX
$7.18M 0.46%
+16,000
New +$230K
NEPT
52
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$7.16M 0.46%
4,822
– –
AGRX
53
DELISTED
Agile Therapeutics
AGRX
$7.12M 0.46%
510
+253
+98% +$3.61M
AGEN
54
Agenus
AGEN
$322M
$6.46M 0.42%
+45,855
New +$5.26M
SNDA icon
55
Sonida Senior Living
SNDA
$1.91B
$6.3M 0.41%
25,020
-14,056
-36% -$3.72M
ARWR icon
56
Arrowhead Research
ARWR
$9.98B
$6.23M 0.4%
+847,458
New +$5.49M
CLVS
57
DELISTED
Clovis Oncology, Inc.
CLVS
$6.18M 0.4%
+171,500
New +$3.68M
XENE icon
58
Xenon Pharmaceuticals
XENE
$5.45B
$6.18M 0.4%
762,800
+330,000
+76% +$2.55M
SUPN icon
59
Supernus Pharmaceuticals
SUPN
$2.4B
$6.05M 0.39%
244,550
-5,450
-2% -$123K
OCGN icon
60
Ocugen
OCGN
$337M
$5.71M 0.37%
+29,630
New +$4.64M
ASMB icon
61
Assembly Biosciences
ASMB
$532M
$5.61M 0.36%
64,806
-1,444
-2% -$112K
CASC
62
DELISTED
Cascadian Therapeutics, Inc.
CASC
$5.6M 0.36%
569,020
– –
KA
63
DELISTED
Kineta, Inc. Common Stock
KA
$5.37M 0.35%
2,461
+675
+38% +$1.25M
ADMA icon
64
ADMA Biologics
ADMA
$1.93B
$5.33M 0.34%
+734,793
New +$4.66M
OTLK icon
65
Outlook Therapeutics
OTLK
$164M
$5.31M 0.34%
7,806
-399
-5% -$254K
AMRN
66
Amarin Corp
AMRN
$294M
$5.17M 0.33%
+81,114
New +$4.55M
RNAC icon
67
Cartesian Therapeutics
RNAC
$239M
$4.96M 0.32%
11,605
-3,395
-23% -$1.33M
NDRM
68
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$4.88M 0.32%
264,114
-5,886
-2% -$102K
ANTH
69
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$4.6M 0.3%
182,453
-4,067
-2% -$103K
CLLS
70
Cellectis
CLLS
$162M
$4.32M 0.28%
179,506
-4,001
-2% -$105K
CEMP
71
DELISTED
Cempra, Inc.
CEMP
$4.25M 0.27%
175,503
+5,503
+3% +$118K
AGTC
72
DELISTED
Applied Genetic Technologies Corporation
AGTC
$4.17M 0.27%
426,048
-232,803
-35% -$3.14M
ABEOW
73
DELISTED
Abeona Therapeutics Inc Warrant
ABEOW
$4.09M 0.26%
1,259,636
– –
ONC
74
BeOne Medicines Ltd
ONC
$39.2B
$4.07M 0.26%
+132,057
New +$3.83M
VTRS icon
75
Viatris
VTRS
$19.1B
$3.61M 0.23%
94,711
+89,711
+1,794% +$3.99M
1 2
3
4 5

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was MEDIVATION, INC., an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings, Inc. worth $16.2M.

  • Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings, Inc.: 2,209,657 shares worth $16.2M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2016, an estimated $14.4M increase.
  • Perceptive Advisors's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $43.1M.
  • Perceptive Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $45.8M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
  • Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
  • Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.